zPREDICTA YC 申请
zPREDICTA 在 Summer 2015 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2015
- 行业
- HealthcareDrug Discovery and Delivery
- 团队规模
- 2
- 状态
- Acquired
- 已发布
- 2015
创始人
Mukti ParikhFounder/CTO
zPREDICTA 做什么
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.
zPREDICTA 的 YC 申请，重建版
Y Combinator 申请
zPREDICTA，Summer 2015 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
zPREDICTA
Patient-derived 3D tissue models for drug testing
We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.
We live in San Jose, CA, and plan to keep the company based here after YC.
San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 zPREDICTA 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 zPREDICTA 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 zPREDICTA 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
zPREDICTA 是哪个 YC 批次的？
zPREDICTA 是 Y Combinator Summer 2015 批次的成员。
谁创立了 zPREDICTA？
zPREDICTA 由 Mukti Parikh 创立。
zPREDICTA 做什么？
Patient-derived 3D tissue reconstruction models for preclinical…
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 zPREDICTA 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 zPREDICTA
